Literature DB >> 10814580

Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.

B A Hendrickson1, J Guo, I Brown, K Dennis, D Marcellino, J Hetzel, B C Herold.   

Abstract

J-chain-deficient (Jch(-/-)) mice were used to study the role of polymeric IgA (pIgA) in primary disease and protective immunity following genital herpes simplex type 2 (HSV-2) infection. Vaginal IgA in the Jch(-/-) mice was composed primarily of monomeric IgA and was not associated with secretory component (SC). In contrast, vaginal IgA in wild-type (WT) mice was predominantly polymeric and bound to SC. Following HSV-2 genital infection, the Jch(-/-) mice consistently exhibited fewer vaginal symptoms (P = 0.010) and mortality (P = 0.075) than did the WT mice. The variation in disease expression could not be explained by differences in local viral replication, since titers in vaginal wash fluid were comparable. To assess the effect of J chain deficiency on protective immunity, WT and Jch(-/-) mice were immunized intravaginally with attenuated HSV-2, challenged intravaginally with wild-type virus 5 weeks later, and evaluated for vaginal infection and neurological disease. Although the Jch(-/-) mice had reduced vaginal HSV-specific IgA and IgG levels following immunization, both WT and Jch(-/-) mice were protected from symptoms following wild-type virus challenge. We conclude that pIgA is not required for protective immunity against genital HSV-2 disease and that J chain deficiency offers some protection against symptoms following primary HSV-2 genital infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814580     DOI: 10.1006/viro.2000.0303

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.

Authors:  Briana Nixon; Esra Fakioglu; Martha Stefanidou; Yanhua Wang; Monica Dutta; Harris Goldstein; Betsy C Herold
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

3.  The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.

Authors:  Kieran Seay; Nazanin Khajoueinejad; Jian Hua Zheng; Patrick Kiser; Christina Ochsenbauer; John C Kappes; Betsy Herold; Harris Goldstein
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

4.  Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections.

Authors:  Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Mohamed Mahmoud; Alfred B Jenson; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  J Control Release       Date:  2020-02-05       Impact factor: 9.776

5.  Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice.

Authors:  Noriko Kato-Nagaoka; Shin-Ichiro Shimada; Yoko Yamakawa; Satoshi Tsujibe; Tomoaki Naito; Hiromi Setoyama; Yohei Watanabe; Kan Shida; Satoshi Matsumoto; Masanobu Nanno
Journal:  Immunology       Date:  2015-06-26       Impact factor: 7.397

6.  Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.

Authors:  Briana Nixon; Thomas Jandl; Ryan S Teller; Ekaterina Taneva; Yanhua Wang; Umadevi Nagaraja; Patrick F Kiser; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

7.  Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.

Authors:  Briana Nixon; Martha Stefanidou; Pedro M M Mesquita; Esra Fakioglu; Theodore Segarra; Lisa Rohan; William Halford; Kenneth E Palmer; Betsy C Herold
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

8.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Rapid-Release Griffithsin Fibers for Dual Prevention of HSV-2 and HIV-1 Infections.

Authors:  Kenneth E Palmer; Jill M Steinbach-Rankins; Kevin M Tyo; Amanda B Lasnik; Longyun Zhang; Alfred B Jenson; Joshua L Fuqua
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

10.  Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.

Authors:  Sarah S Wilson; Natalia Cheshenko; Esra Fakioglu; Pedro M M Mesquita; Marla J Keller; Betsy C Herold
Journal:  Antivir Ther       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.